749929-86-0

Basic information

• Product Name: 2-(4-Bromo-2-chloro-phenyl)-2-methyl-propionitrile
• Synonyms: 2-(4-Bromo-2-chloro-phenyl)-2-methyl-propionitrile
• CAS NO: 749929-86-0
• Molecular Weight: 258.545
• Mol File: 749929-86-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(4-Bromo-2-chloro-phenyl)-2-methyl-propionitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-Bromo-2-chloro-phenyl)-2-methyl-propionitrile(749929-86-0)
• EPA Substance Registry System: 2-(4-Bromo-2-chloro-phenyl)-2-methyl-propionitrile(749929-86-0)

Safety Data

• Hazardous Substances Data: 749929-86-0(Hazardous Substances Data)

Upstream product

• 78-82-0 Isobutyronitrile 
• 60811-21-4 1-bromo-3-chloro-4-fluorobenzene 
• 74-88-4 methyl iodide 
• 67197-54-0 2-(4-bromo-2-chlorophenyl)acetonitrile 

Downstream Products

• 945619-17-0 C₂₅H₂₈ClNO₄ 

Relevant articles and documents

CYANOCYCLOPROPYLCARBOXAMIDES AS CATHEPSIN INHIBITORS

The present invention relates to compounds of formula (I) for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases, including cathepsins B, K, C, F, H, L, O, S, W and X. Of particular interest are diseases associated with Cathepsin K.

INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME

The present invention provides compounds of formula (4), and their pharmaceutically acceptable salts and solvates, which are useful as inhibitors of the Hepatitis C virus (HCV) polymerase enzyme and are also useful for the treatment of HCV infections in HCV-infected mammals. The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates. Furthermore, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formula (4).